☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
dong-a st
Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)
October 22, 2024
Dong-A ST Reports the US FDA’s Approval of Imuldosa (Biosimilar, Stelara)
October 14, 2024
Dong-A ST Reports P-III Study Results of Ustekinumab Biosimilar DMB-3115 for the Treatment of Chronic Plaque Psoriasis
January 17, 2023
Dong-A ST Signed an Exclusive License Agreement with Polifarma for NESP Biosimilar DA-3880
November 9, 2022
Insights+ Key Biosimilars Events of July 2021
August 5, 2021
Insights+ Key Biosimilars Events of July 2019
August 10, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.